Fig. 3.
SSCP analysis of E2E4 segments amplified from the patients (cases no. 1 and 2) at the initial onset. Lanes 1 and 4, HL-60 without mutation; lanes 2 and 3, cases no. 1 and 2 at the initial onset, respectively.
SSCP analysis of E2E4 segments amplified from the patients (cases no. 1 and 2) at the initial onset. Lanes 1 and 4, HL-60 without mutation; lanes 2 and 3, cases no. 1 and 2 at the initial onset, respectively.
